Only four out of 10,000 people received both doses of Covaxin Bharat Biotech and three out of 10,000 received both doses of Covishield Oxford-AstraZeneca which turned positive for Covid-19 after vaccination, data showed the government on Wednesday, noting that the vaccines available in India have reached their goal against the viral disease.
In absolute numbers, 695 recipients (0.04%) were among the 17,37,178 recipients of two doses of Covaxin and 5,014 recipients (0.03%) of the total 1,57,32,754 recipients to have received two doses From Covishield – which is manufactured locally by the Indian Serum Institute (SII) – got the infection after the injections, the data showed.
The figures that show such low infection rates among vaccinated people come at a time when the effectiveness of the shots available in India has been called into question, though experts and scientists have conducted a spontaneous vaccination drive is the only way to combat the pandemic. Wednesday’s data will help further dispel doubts and provide a huge boost to India’s fight against Covid-19.
Separately, the Medical Research Council of India and Bharat Biotech released another set of provisional findings from clinical trials, showing that the indigenous Covaxin is 100% effective against severe Covid – meaning those who do not receiving the vaccine is going to become seriously ill with the disease. In February, AstraZeneca had said its Covishield vaccine was 100% effective in preventing serious illness, hospitalization and death.
Taken together, the data shows that the two vaccines currently used in India offer full protection against serious disease, an encouraging statistic that shows increasing vaccine coverage will reduce ‘ r the burden on Indian hospitals and the rapidly shifting healthcare sector due to anxiety. second wave.
Government data on Wednesday also showed that a total of 1.1 crore people had received Covaxin; 93, 56, 436 beneficiaries received the first dose only, while 4,208 (0.04%) turned positive after the shot. In the case of Covishield, a total of 11.6 crore people received the vaccine; 10,03,02,745 received the first dose only and 17,145 (0.02%) turned positive after receiving the injection.
Experts say that no vaccine can claim to have a 100% success rate against the disease, but they do prevent it in most cases; there are signs from all over the world that they are also preventing the serious outbreak. Chances of Covid-19 infection after having the two doses – Covaxin and Covishield are two-dose vaccines – are rare, an argument that was properly proved by India’s data on Wednesday.
There are very few what experts call “groundbreaking cases”. They may be caused mainly by failure to adhere to Covid-appropriate behavior (hiding and social distance) and high exposure to the Sars-Cov-2 virus that causes Covid-19.
Read all the Latest News and Breaking News here